The mPEG5kDa-cholane/GlaB micellar system can be properly exploited in the treatment of patients with medulloblastoma, particularly for those tumors showing resistance to SMO inhibitors or harboring GLI1 hyperactivation by SMO-independent mechanisms [159]. This evidence concerns the gene SMO and medulloblastoma.